Could cause temporary or reversible harm; serious harm is unlikely.
Defective Container: Customer complaints received of a crimp defect while removing the flip-cap during use.
| Brand name | IRINOTECAN HYDROCHLORIDE |
| Generic name | IRINOTECAN HYDROCHLORIDE |
| Active ingredient(s) | IRINOTECAN HYDROCHLORIDE |
| Distributed by / for | West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA |
| NDC | 0143-9701-01 |
| Full product label | Irinotecan HCL Injection, USP, 100mg/5mL, 5 mL vials, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Shiffgraben 23, 38690 Golsar, Germany Distributed by: West-Word Pharmaceutical Corp. Eatontown, NJ 07724 USA, NDC 0143-9701-01 |
| Recalling firm | Hikma Pharmaceuticals USA Inc. |
| Distribution | Nationwide within the United States |
| Quantity | 82,426 vials |
| Recall initiated | 2020-06-11 |
| Report date | 2020-06-24 |
| Recall completed | 2021-06-10 |
| Recall number | D-1308-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Cherry Hill NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗